Qube Research & Technologies Ltd

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in FULC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,399,389

-$1,076,859 QoQ

Shares Held

1,748,467

+79.4% QoQ

Ownership

2.29%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#13

of 154 holders

Holding Since

Jun 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. FULC ranks #68 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,399,389	1,748,467	+79.4%	Shares	Sole	2026-08-14
2026-03-31	$7,476,248	974,739	+148.3%	Shares	Sole	2026-05-15
2025-12-31	$4,439,050	392,489	-29.1%	Shares	Sole	2026-02-17
2024-06-30	$3,430,502	553,307	-23.5%	Shares	Sole	2024-08-14
2024-03-31	$6,826,658	723,163	+197.7%	Shares	Sole	2024-05-14
2023-12-31	$1,639,629	242,908	+1759.1%	Shares	Sole	2024-02-13
2023-09-30	$58,013	13,066	-58.9%	Shares	Sole	2023-11-13
2022-06-30	$155,883	31,813	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.